Menu
Recruiting NCT01984762

Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.

No phase Interventional Obesity Type 2 Diabetes Bariatric Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Roux-en-Y gastric bypass, sleeve gastrectomy.
Who it may be relevant to
Registry conditions: Obesity, Type 2 Diabetes, Bariatric Surgery. Basic parameters: 18 years — 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Sweden
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus. Randomised Controlled Trial

Overview

Obesity is a growing epidemic throughout the world and is followed by increasing incidence of type 2 diabetes that accounts for 90-95% of all cases of diabetes. Weight loss is a major objective, although difficult to achieve with medical treatments. Many recent studies demonstrated that bariatric surgery has the potency to achieve marked and sustained weight loss, and is also associated with a significant improvement in control of type 2 diabetes. The principal aim of this study is to compare two types of bariatric procedures, the Roux-en-Y gastric bypass (RYGBP) and sleeve gastrectomy (SG). The study hypothesis is that these procedures have equal efficacy with regard to resolution of type 2 diabetes.

Interventions

  • Procedure Roux-en-Y gastric bypass
    RYGBP=Roux-en-Y gastric bypass
  • Procedure sleeve gastrectomy
    SG = sleeve gastrectomy

Primary outcome measures

  • Rate of resolution of type 2 diabetes [Time frame: 5 years]
Secondary outcome measures (1)
  • postoperative complications [Time frame: 5 years]

Eligibility criteria

Inclusion criteria

  • Type 2 diabetes mellitus
  • BMI between 35 and 50kg/m2.
  • Males and females
  • Age between 18 and 60 years.

Exclusion criteria

  • Severe ongoing psychiatric disorder, alcoholism and substance abuse.
  • Redo operations after previous bariatric procedures.
  • Type 1 diabetes or other non-type 2 forms of diabetes
  • End stage renal disease, retinopathy, neuropathy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Sweden · 1 center
  • Sahlgrenska University Hospital — Gothenburg

Identifiers

NCT: NCT01984762 · 684-11

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗